Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis.

Medicine (Baltimore) · 2018 · PMC6024095 · PMID 29901640

Europe PMC DOI

hedged sentence

0.6100

closest p · 12.2× alpha

0.6100

boldest claim

The sentences

showed a trendP = .61not close (p > 0.1)

Combining the data from 7 studies also showed a trend that high GPC3 expression was not associated with the tumor size ≥ 5 cm (OR: 1.08, 95% CI: 0.80–1.47, P = .61; Fig. 6 E).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.